Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based President operating in the Medical space. If you think a President is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Mark Mallon
Executive Vice President, Global Product and Portfolio Strategy, Medical Affairs and Corp. Affairs of AstraZeneca
Mark Mallon is responsible for the growth and performance of AstraZeneca’s International region, which predominantly includes AstraZeneca’s commercial businesses in Asia Pacific, Russia, Latin America, the Middle East and Africa. Most recently, Mark served as Regional Vice President for Asia Pacific where he was accountable for the growth and performance of the AstraZeneca business in 14 markets. While in this role Mark has also served as President of AstraZeneca China, responsible for the company’s overall operations in China and Hong Kong. Previously, Mark led the marketing, sales and commercial operations for AstraZeneca K. K. (Japan). Since joining AstraZeneca in 1994, Mark has held a number of additional leadership roles, Including Marketing Company President of the AstraZeneca Italian subsidiary company and Vice President of Marketing and Sales Operations of AstraZeneca’s US business. While in the US, Mark also was a Board Member for the Christiana Care Network, one of the the largest healthcare networks on the East Coast. Mark received a Bachelor of Science degree in Chemical Engineering from the University of Pennsylvania and an MBA in Marketing and Finance from the Wharton School of Business. He is based in Shanghai.
Follow Mark Mallon:
About AstraZeneca, NeoGenomics: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
_______
Sean Bohen
Executive Vice-President, Global Medicines Development and Chief Medical Officer of AstraZeneca
Sean was appointed Executive Vice-President, GMD in September 2015 and leads our global late-stage development organisation for both small molecules and biologics. He is also the Company’s Chief Medical Officer and is responsible for patient safety across the entire AstraZeneca and MedImmune portfolio. He joined AstraZeneca from Genentech, where he held a number of senior leadership roles across various therapy areas and was most recently Senior Vice President of Early Development. Before joining Genentech, Sean was a Clinical Instructor in Oncology at Stanford University School of Medicine, a research associate at the Howard Hughes Medical Institute and a postdoctoral fellow at the National Cancer Institute. He is a graduate of the University of Wisconsin and later earned his doctorate in biochemistry and his medical degree at the University of California, San Francisco.
Follow Sean Bohen:
About AstraZeneca: AstraZeneca is a global pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines.
Thomas Joyce
President & CEO of Danaher
Thomas Joyce is President and Chief Executive Officer of Danaher Corporation, a position he assumed in September 2014. Thomas is responsible for the company’s strategic vision and leads the development and growth of Danaher’s global science and technology portfolio. Thomas has more than 20 years of Danaher leadership experience. Prior to his appointment as President and Chief Executive Officer, he served as Executive Vice President of Danaher Corporation, responsible for Danaher’s Water Quality platform and Life Sciences & Diagnostics segment. In this role, Thomas increased Danaher’s Water Quality revenue by over $1.5 billion and led the company’s major acquisitions of Beckman Coulter and AB SCIEX. Throughout his tenure, Thomas has also played a key role in developing and evolving the Danaher Business System, Danaher’s common operating philosophy. Thomas began his Danaher career in 1989 as a Project Manager in the Danaher Tool Group, and later transitioned into a manufacturing role. In 1995, Thomas became President of Delta Consolidated Industries. Following this assignment, he became President of Hach Company, the world leader in analytical instrumentation for drinking water and wastewater applications in 2001. In 2002, Thomas became a Group Executive and Corporate Officer with Danaher Corporation, which led to his transition to Executive Vice President in 2006. Prior to joining Danaher, Thomas worked as a management consultant at Anderson Consulting, where he worked with a large number of manufacturing businesses to implement lean tools and optimize transactional processes. Thomas was born and raised on the north shore of Chicago and earned his bachelor’s degree in Economics from the College of the Holy Cross in 1982. He and his wife, Claire, live in Washington, D.C. and have four children.
Follow Thomas Joyce:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
William H. King, IV
Senior Vice President, Strategic Development of Danaher
Mr. King is the Senior Vice President, Strategic Development for Danaher Corporation. Mr. King and his team drive market development, deal sourcing and commercial diligence at Danaher, thus co-owning the M&A process at Danaher with Mr. Daniel Raskas and the Corporate Development team. In addition, he and his team hold responsibility for the strategic planning process, tools and training. Mr. King joined Danaher in 1998 and has held positions as Managing Director of the Special Purpose Systems Motion Control Group, as well as Vice President of Sales and Marketing for the Motion Control Group. Prior to joining Danaher, he held positions of increasing responsibility in live production and logistics for Perdue, Inc. Mr. King has an MBA from Harvard Business School and a BS in Economics from University of Maryland.
Follow William H. King, IV:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Brenton Saunders
Chairman, President and Chief Executive Officer of Allergan
Brent Saunders is Chief Executive Officer and President of Allergan plc (formerly Actavis plc). Brenton previously served as Chief Executive Officer and President of Forest Laboratories and had served as a Member of the Board of Directors at Forest since 2011. Brenton has significant healthcare industry expertise and a proven track-record leading business transformations and integrations. Prior to Forest, Brenton was Chief Executive Officer of Bausch + Lomb, a leading global eye health company, serving in this capacity from March 2010 until August 2013. Brenton also held a number of leadership positions at Schering-Plough, including the position of president of Global Consumer Health Care and was named head of integration for the company’s merger with Merck & Co. and for Schering-Plough’s acquisition of Organon BioSciences. Before joining Schering-Plough, Brenton was a Partner and Head of Compliance Business Advisory at PricewaterhouseCoopers LLP. Prior to that, Brenton was Chief Risk Officer at Coventry Health Care and Senior Vice President, Compliance, Legal and Regulatory at Home Care Corporation of America. Brenton began his career as Chief Compliance Officer for the Thomas Jefferson University Health System. Brenton serves on the Board of Trustees of the University of Pittsburgh. Brenton is also the former Chairman of the New York chapter of the American Heart Association. Brenton is a Member of the Business Council and PhRMA. Brenton earned his MBA from Temple University School of Business, his J.D. from Temple University School of Law and his Bachelor’s degree from the University of Pittsburgh.
Follow Brenton Saunders:
About Allergan, Cisco: Allergan is a global pharmaceutical company.
Raymond H. Diradoorian
Executive Vice President of Allergan
Mr. Diradoorian has been Executive Vice President, Global Technical Operations since February 2006. From April 2005 to February 2006, Mr. Diradoorian served as Senior Vice President, Global Technical Operations. Since February 2001, Mr. Diradoorian served as Vice President, Global Engineering and Technology. Mr. Diradoorian joined Allergan in July 1981. Prior to joining Allergan, Mr. Diradoorian held positions at American Hospital Supply and with the Los Angeles Dodgers baseball team. Mr. Diradoorian received a Bachelor of Science degree in Biological Sciences from the University of California, Irvine and a Master of Science degree in Technology Management from Pepperdine University.
Follow Raymond H. Diradoorian:
About Allergan: Allergan is a global pharmaceutical company.
Stephen Barat
Associate Vice President, Non-Clinical Development of Allergan
Stephen Barat is currently the Executive Director of Non-clinical and Translational Sciences – Safety Assessment and Bioanalysis for Allergan. He has 20 years of experience in global drug development and registration, with a specific interest in drug device combinations, the interface of safety assessment and CMC requirements, and extensive experience in the safety assessment of impurities. Dr. Barat is a member of the PQRI – PDP working group and toxicology sub-team as well as the USP Expert Panel for Biocompatability of Packaging Materials.
Follow Stephen Barat:
About Allergan, The Janssen Pharmaceutical Companies of Johnson & Johnson: Allergan is a global pharmaceutical company.
Joe Caltabiano
Co-Founder and President of Cresco Labs
Joseph “Joe” Caltabiano is a well-known and influential figure in the cannabis business, as well as the CEO of Choice Consolidation Corp., a special purpose acquisition company (“SPAC”) targeting an acquisition of one or more cannabis businesses or assets that can create a best-in-class cannabis multi-state operator (“MSO”). Prior to launching Choice, Caltabiano co-founded Cresco Labs, one of the most successful multi-state operators in the United States. Living and working in the Chicago metropolitan area, Caltabiano is a mentor who regularly advises both new and existing companies. His experience has covered a broad spectrum of disciplines, and he uses this diverse and extensive financial knowledge of retail, real estate, management, and the regulated cannabis sector to uncover new possibilities for investors. As a philanthropist and a childhood leukemia survivor, Caltabiano is also a significant contributor to organizations seeking a cure for cancer and supporting patients and their families.
Follow Joe Caltabiano:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Rukiya Packer
Vice President of Vitality Medical
Rukiya Packer is the Vice President at Vitality Medical.
Follow Rukiya Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Adam Dunn
Vice President Information Technology Operations of Vitality Medical
Adam is a full time problem solver. He graduated from Brigham Young University in 2010 with a B.S. in Information Science and Technology and later graduated with his M.S. in Information Systems from Utah University in 2013. Since starting with Vitality Medical in 2009, Adam assumes the role of IT Director by using his web experience to improve customer’s online experience. Before working at Vitality Medical, Adam worked as an Operations Specialist for a local credit union where he managed web development and online processes to streamline consumer loans.
Follow Adam Dunn:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Denise Castillo Rhodes
Executive Vice-President & Chief Financial Officer of Texas Medical Center
Denise Castillo-Rhodes is executive vice president and chief financial officer of Texas Medical Center, where she oversees accounting, finance, billing and collections, and tax compliance. Outside of her work at Texas Medical Center, Castillo-Rhodes serves on several advisory boards, including Post Oak Montessori School, The Audit and Finance Committee of Medical Bridges, Houston Livestock Show and Rodeo Ticket Services, Greater Houston Partnership’s Executive Women’s Partnership, and Greater Houston Women’s Chamber of Commerce. Castillo-Rhodes holds a Bachelor of Business Administration from the University of Texas at El Paso and a Master of Business Administration from the University of St. Thomas. She is a certified public accountant and is a member of the Texas Society of Certified Public Accountants and American Institute of Certified Public Accountants.
Follow Denise Castillo Rhodes:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Robert C Robbins
President and CEO of Texas Medical Center
Robert C. Robbins became President and Chief Executive Officer of Texas Medical Center on November 5, 2012. Prior to that, he was professor and chairman of the Department of Cardiothoracic Surgery at Stanford University School of Medicine, where he served as a member of the faculty since 1993. He served as director of the Stanford Cardiovascular Institute, of the Heart- Lung and Lung Transplantation Programs, and of the Cardiothoracic Transplantation Laboratory. Dr. Robbins is an internationally recognized cardiac surgeon who has focused his clinical efforts on acquired cardiac diseases with a special expertise in the surgical treatment of congestive heart failure. His research work includes the investigation of stem cells for cardiac regeneration, cardiac transplant allograft vasculopathy, bioengineered blood vessels, and automated vascular anastomotic devices. He served as the guest editor of the Circulation Surgical Supplement from 2002 to 2005, president of the International Society of Heart and Lung Transplantation in 2006, president of the Bay Area Society of Thoracic Surgeons in 2006, chair of the American Heart Association Cardiovascular Surgery and Anesthesia Council from 2007 to 2009, councilor-at-large for the Western Thoracic Surgical Association from 2007 to 2009, and on the President’s Cabinet at California Polytechnic State University from 2006 to 2012. In California, he served on the Board of Directors for two publically traded companies, Cohesion Technologies from 2000 to 2003 and Cardica, Inc. from 2000 to2009, and as a director for several other privately held Bay Area biotechnology companies. In 2009, he was elected to the American Heart Association Western States Affiliate Board of Directors and currently serves as president of the organization. He was elected to the Board of Trustees of Millsaps College in Mississippi in 2010. Dr. Robbins has lectured widely and published more than 292 peer reviewed articles. He earned his bachelor’s degree in chemistry from Millsaps College in 1979 and a medical degree from the University of Mississippi in 1983. He completed his general surgical training at the University of Mississippi in 1989 and his cardiothoracic training at Stanford University in 1992. Dr. Robbins completed post-doctoral research at Columbia University and the National Institutes of Health, and congenital heart surgical fellowships at Emory University and Royal Children’s Hospital. An ex-officio of the Houston Livestock Show & Rodeo, Dr. Robbins currently sits on the Advisory Board of the Ronald McDonald House in Houston and on the Board of Directors for Texas Medical Center, the Greater Houston Partnership, the Greater Houston Convention and Visitors Bureau, the Houston Academy of Medicine Texas Medical Center Library, the Houston Technology Center, and the Friends of Houston Academy of Medicine Texas Medical Center Library.
Follow Robert C Robbins:
About Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
William McKeon
Executive Vice President, Chief Strategy & Operating Officer of Texas Medical Center
William McKeon is the executive vice president, chief strategy officer, and chief operating officer of Texas Medical Center. He is responsible for driving strategic, operational and programmatic initiatives across the Texas Medical Center’s member institutions to enhance its leadership position in the life sciences. McKeon has served as an executive for some of the leading companies and institutions in the world, including: Du Pont, Stanford University Medical Center, Raytel, US Oncology, Medtronic, MicroPort (Shanghai) and Cellnovo. He has served as the chief executive officer for industry-changing companies in Shanghai, China, and London, UK and raised over $67 million in equity financing. McKeon was twice awarded the Computer World – Smithsonian Award in Medicine for innovations in cardiovascular monitoring and the automation of matching cancer patients to clinical trials. He holds a Bachelor of Science in legal studies from Roger Williams University and earned a Master’s Degree from the University of San Francisco – School of Management.
Follow William McKeon:
About Texas Medical Center, Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
RJ Fitch
Vice President Operations & General Manager of WuXi AppTec
Innovative senior management leader Raymond J. “RJ” Fitch possesses more than two decades of experience in the biotech and global healthcare industries. As the Vice President of Operations & General Manager for WuXi AppTec Advanced Therapies, Mr. Fitch leverages his knowledge of site operations and supply chain functions to oversee logistics operations, biological testing services, engineering, and other operations at the company’s Philadelphia location. RJ Fitch is responsible for three facilities within the Philadelphia site. Mr. Fitch began his career more than 20 years ago, graduating from Philadelphia University with a bachelor of science in biology. After working for Merck & Company, he joined Sanofi Pasteur as a director of vaccine aseptic filling & formulation. He stayed with the company for seven years, rising through the ranks to become the senior director of influenza viral manufacturing. Mr. Fitch later served as the associate vice president at Genzyme, a Sanofi company, and vice president of Sanofi Pasteur in Toronto, Canada. During his time with Sanofi Pasteur, RJ Fitch returned to school to earn an executive MBA from the New York University Stern School of Business.
Follow RJ Fitch:
About WuXi AppTec: WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical.
Richard Kolodny
President of Drive Medical
Richard Kolodny is a principal founder of the Company. Richard joined the Company in April 2003 as Executive Vice President, Chief Financial Officer and General Counsel, and became President in 2008. From 1999 through March 2003, Richard was a corporate partner in the law firm of Jenkens & Gilchrist Park Chapin, LLP. Richard specialized in the areas of general corporate and securities laws. From 1993 through 1999, Richard served as the Executive Vice President and General Counsel of a publicly traded healthcare company where he served as a member of the Board of Directors of such company’s domestic and international operating companies. Prior to such time, Richard was associated with the New York law firm of Shea and Gould.
Follow Richard Kolodny:
About Drive Medical, Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Joseph Lewarski
Senior Vice President/General Manager, Clinical Care & North America Manufacturing of Drive Medical
Follow Joseph Lewarski:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Karen Lerner
Regional Vice President of Pressure Prevention of Drive Medical
Karen is a registered nurse, wound care and rehab specialist with over 25 years of industry experience. Karen has extensive experience as a public speaker, educating DME providers and clinicians on a variety of topics. Karen’s speaking engagements included testifying before Congress on behalf of the HME industry. Since October 2013, Karen has worked as part of Team Pressure Prevention at Drive Medical. Prior to coming to Drive and for over 10 years, Karen was VP of Clinical Services at a Northeast based DME, responsible for Pressure Prevention, Respiratory and Rehab sales, as well as service and training. Before DME, Karen worked in sales for a hospital equipment and support surface manufacturer. Karen began her career as a critical care nurse specialist in major teaching hospitals from Florida to NJ. Karen received her undergraduate degree from Duke University and her graduate education from the University of Florida.
Follow Karen Lerner:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Josh Gordon
Vice President of Inside Sales for North America of Drive Medical
After graduating from Penn State University in 1999, Joshua Gordon spent several years growing a sales portfolio in recruiting and admissions for the Katharine Gibbs School. Josh joined Drive Medical in 2002 as a Territory Business Manager for the Philadelphia Region. In 2009, Josh took his experience from outside sales and developed a new Inside Sales Department for the company.
Follow Josh Gordon:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Michael Serhan
Executive Principal & Executive Vice President of Product Development of Drive Medical
Michael Serhan is an Executive principal to Drive Medical. Michael joined the company in 2004, with the Company’s merger of Dr. K international, a West Coast manufacturer and distributor of durable medical products, where he served as President and Principal stock holder. At Dr.K, Mr. Serhan was able to redirect the company’s direction and grow annual revenues to approximately $14 million. In the industry from 1987, Michael has served as West Coast division President of an approximately $180 Million publicly traded company. Michael is primarily responsible for product development and product design, overseeing core product categories, and handling large national customers for Drive Medical.
Follow Michael Serhan:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Ryan Mahoney
Regional Vice President – Midwest Sales Division of Drive Medical
A graduate from University of Dayton and previously working for a homecare provider in the Pittsburgh market, Ryan joined Drive Medical in 2009 as a Territory Manager for Western Pennsylvania. With a highly successful territory, Ryan earned the 2010 Rookie of the Year award, the 2011 Rep of the year award and was promoted in 2012 to Vice President of Sales for Drive’s Midwest division.
Follow Ryan Mahoney:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Jeffrey Schwartz
Executive Vice President of Sales of Drive Medical
Jeffrey Schwartz is a principal founder of Drive medical. Jeffrey served as the Vice President of Sales of Diamond Medical and National Healthcare from 1987 until 1992. Following the sale to a publicly traded healthcare company, Jeffrey served as the Vice President of Sales of such public company until 1996. In 1996, Jeffrey formed Jofra Enterprises, Inc., a distributor of medical products, located in Mt. Vernon, New York, which was subsequently acquired by a publicly traded healthcare company in 1998. Jeffrey served as the Executive Vice President of Sales of the publicly traded healthcare company from 1998 through 2000.
Follow Jeffrey Schwartz:
About Drive Medical, Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Rowley Jackson
Senior Vice President of Corporate Accounts of Drive Medical
Rowley Jackson has been in the medical products industry for over 25 years and has served in many capacities from managing sales to product development. Rowley has been with Drive Medical since the beginning. He was the first vendor for Drive, supplying product from a domestic manufacturer where he served as the Executive Vice president. Rowley joined Drive in January of 2001 to create its initial sales force.
Follow Rowley Jackson:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Seth Diamond
Vice President of Ecommerce Division of Drive Medical
Seth Diamond has been part of the Drive team since its inception. In his tenure, Seth has held many roles and his diverse contributions have made him an integral factor in Drive success. His knowledge of durable medical equipment, sales experience and background in Ecommerce has allowed him to flourish as V.P. of the Ecommerce Division. Seth’s responsibilities include the management and development of the Drive brand via the World Wide Web.
Follow Seth Diamond:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Greg Eaton
Regional Vice President of Respiratory Sales of Drive Medical
Greg Eaton started with Drive Medical in July of 2015 through the acquisition of DeVilbiss Healthcare. Greg brings over 29 years of medical sales and sales management experience in Orthopedics, Spine, Sleep and Respiratory. Greg started his medical career with Medtronic as a territory sales manager in Indianapolis, and earned President’s Club honors in his first year. Medtronic promoted him to management covering the Southeast District based out of North Carolina. Greg then moved to a start up territory opportunity with ResMed, specializing in sleep disordered breathing. During his tenure, Greg was instrumental in growing a small market of less than $500,000 annual sales to a market of $50 million and was honored with 5 President’s Club awards. Greg then accepted an opportunity in the Spine industry with Orthofix as the Regional Director. His leadership took the Mid-Atlantic Region to 3 consecutive years as Region of the Year and President’s Club honors. After his time with Orthofix, Greg was recruited back to the Sleep and Respiratory industry by Devilbiss Healthcare as the Eastern Region Manager.
Follow Greg Eaton:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Francheska Markman
Vice President of Customer Service of Drive Medical
Francheska Markman is a Customer Service and Call Center professional with over 18 years of experience. Most recently, Francheska led and directed a 65-seat Customer Service and Accounts Receivable Departments at Southern Wine and Spirits, a mutli-million dollar national distributor of adult beverages. Francheska has been recognized for her strength in strategic work flow planning, managerial expertise of a fast paced, high volume call center, resourcefulness and commitment to success.
Follow Francheska Markman:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Tony Crisitello
Senior Vice President of Long Term Care of Drive Medical
Tony Crisitello joined Drive Medical in 2014 as Senior Vice President – Long Term Care. Tony responsible for strategic development and growth of this division through both acquisitions and organic growth in North America. Prior to joining Drive Medical, Tony was Co-Founder and President of Next Day Medical, a regional distribution business based in Baltimore, MD. Tony sold this business to McKesson Medical Surgical in 2012, and held various leadership positions in their organization during the two year integration period of Next Day Medical. Tony holds a degree in marketing from Old Dominion University and has attended several executive level programs at NYU Stern School of Business, Stanford Graduate School of Business, and Duke University’s Fuqua School of Business.
Follow Tony Crisitello:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Vanessa Saltmarsh
Regional Vice President of Drive Medical
Vanessa Saltmarsh joined Drive Medical in 2012 as the Director of Respiratory Business Services. In this role, she called on her 16+ years of industry related experience to provide direction and leadership to key accounts. Prior to joining Drive Medical, Vanessa began her career at evo Medical Solutions, where she took on progressively responsible roles in the areas of sales, marketing, and operational management. Vanessa has been recognized as a leader in respiratory sales, program development and strategic account management. In August 2015, Vanessa was promoted to Regional Vice President of Respiratory Sales, where she owns responsibility for key account management, training, marketing communications content, and salesforce clinical support for Drive’s respiratory category.
Follow Vanessa Saltmarsh:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Thomas Antonio
Vice President of Financial & CFO of Drive Medical
Thomas Antonio joined the Company in February 2004, and is primarily responsible for financial reporting. From 1986 through 1997, Thomas Antonio served as the Assistant Vice President and Controller of Charan Industries, a privately-held company which owned and operated bowling centers throughout the United States. From 1997 through February 2004, Thomas served as the Chief Financial Officer of several privately-held companies located in the metropolitan New York area.
Follow Thomas Antonio:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Dan O’Malley
Regional Vice President of Pressure Prevention Sales of Drive Medical
Dan O’Malley joined Drive Medical in 2013, as Regional VP of Pressure Prevention Sales in connection with the Company’s acquisition of a national manufacturer of durable medical products. Dan is primarily responsible for the Company’s category sales in Pressure Prevention for the homecare and long term care markets. Dan has 20 years of experience working in the acute care, long term care, and homecare settings in the medical device, rehabilitation, and durable medical equipment industries. More recently, Dan served as the National Sales Manager for Mason Medical Products, a manufacturer of Pressure Prevention products. Dan is a 1995 graduate of the University of Massachusetts.
Follow Dan O’Malley:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Steve Wakser
Vice President of Sales for Southeast of Drive Medical
Steve Wakser started with Drive in January 2009, with over 10 years of experience in the DME industry running a successful dealership in Ohio. Steve quickly grew his Michigan territory to top numbers and achieved Rookie of the Year in 2009 and Rep of the Year in 2010, with over $6 million in sales. Continued success led Steve to Regional Vice President of the Southeast in 2012. Steve holds a Bachelors Degree in Communications from Kent State University.
Follow Steve Wakser:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Jim McGuiness
Vice President of Sales – Retail Division of Drive Medical
Jim McGuiness joined Drive Medical in March of 2010. Jim brings over 25 years of executive sales leadership experience from the Consumer Package Goods industry (GSK & Bayer Consumer Healthcare). Jim is a graduate of LSU and currently resides in Dallas, Texas. Jim is responsible for leading the Retail Sales Division for Drive Medical.
Follow Jim McGuiness:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Christopher Cheek
Vice President of Distributor Sales of Drive Medical
Christopher Cheek joined Drive Medical in July of 2014 as Vice President of Distributor Sales through the acquisition of MEDQUIP Inc. Christopher brings with him over 25 years of successful experience within the medical products industry and has specialized in distributor-wholesale partner management for most of his profession. In January 2006, Christopher joined MEDQUIP shortly after its inception as National Sales Manager and relocated to the company’s headquarters in South Carolina in 2008, where Christopher served as the organization’s Vice President and General Manager. Throughout his career, Christopher has served in many capacities within the industry including Director of Business Development for a major manufacturer and distributor of orthotic braces, compression hosiery and durable medical equipment. Other positions held include National Sales Manager of a leading Medical Hosiery Manufacturer. Christopher’s experience within the industry is comprised of an extensive history within the business and has a strong acumen in sales management, marketing, product development, sales training and continuing education.
Follow Christopher Cheek:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Christopher Cheek
Vice President of Distributor Sales of Drive Medical
Christopher Cheek joined Drive Medical in July of 2014 as Vice President of Distributor Sales through the acquisition of MEDQUIP Inc. Christopher brings with him over 25 years of successful experience within the medical products industry and has specialized in distributor-wholesale partner management for most of his profession. In January 2006, Christopher joined MEDQUIP shortly after its inception as National Sales Manager and relocated to the company’s headquarters in South Carolina in 2008, where Christopher served as the organization’s Vice President and General Manager. Throughout his career, Christopher has served in many capacities within the industry including Director of Business Development for a major manufacturer and distributor of orthotic braces, compression hosiery and durable medical equipment. Other positions held include National Sales Manager of a leading Medical Hosiery Manufacturer. Christopher’s experience within the industry is comprised of an extensive history within the business and has a strong acumen in sales management, marketing, product development, sales training and continuing education.
Follow Christopher Cheek:
About Drive Medical: Drive Medical is one of the fastest growing global distributors of durable medical equipment.
Tom Roos
Senior Vice President & Chief Accounting Officer of UnitedHealth Group
Tom Roos was appointed chief accounting officer for the enterprise in August 2015. He is responsible for SEC reporting, accounting policy, tax and enterprise risk management. Previously, Roos was a Partner at Deloitte & Touche LLP for eight years, where he worked closely with Deloitte & Touche’s national office and industry leaders on emerging technical accounting and reporting matters in the health insurance industry, with experience in company mergers and acquisitions and initial public offerings
Follow Tom Roos:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
John Cosgriff
Chief Strategy Officer & Senior Vice President of Business Development of UnitedHealth Group
John Cosgriff is Senior Vice President at UnitedHealth Group, where he focuses on strategy, acquisitions, and new business ventures. UnitedHealth Group is the world’s largest healthcare company, ranking number 14 on the Fortune 100, with 200,000 employees serving over 125 million consumers and revenues of $157 billion. John has completed over $3 billion in acquisitions and created partnerships with Sesame Street, Walmart and NASCAR. Prior to UnitedHealth Group John was a management and technology consultant with Accenture, where he served Fortune 500 companies, nonprofits, and government clients in the United States and Europe. He started his career on Capitol Hill in staff roles in the United States House of Representatives and the United States Senate. John holds an MBA from the University of Chicago and an MPH from the University of Minnesota.
Follow John Cosgriff:
About Hinge Health, Orbit Fab, Seasats, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Richard Migliori
Office of the Chief Executive, Executive Vice President, Medical Affairs & Chief Medical Officer of UnitedHealth Group
In 2013, Richard Migliori, M.D. was appointed executive vice president, Medical Affairs, and chief medical officer, UnitedHealth Group, working with businesses across the enterprise to help improve health care quality, access and affordability. Previously, as executive vice president for Health Services, Dr. Migliori was responsible for the ongoing development, design, and adaptation of market leading clinical innovations aimed at ensuring clinical excellence, improving clinical and economic outcomes, and delivering robust business performance on behalf of UnitedHealth Group’s largest public and private sector clients
Follow Richard Migliori:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Terry Clark
Senior Vice President & Chief Marketing Officer of UnitedHealth Group
Terry Clark was appointed senior vice president and chief marketing officer, UnitedHealth Group, in 2014. Clark oversees branding, marketing and advertising for UnitedHealth Group and its two operating platforms, UnitedHealthcare and Optum, with responsibility for helping positively shape the customer experience. Previously, Clark served as chief marketing officer, UnitedHealthcare Medicare & Retirement, where he led marketing and direct-to-consumer engagement efforts focused on seniors. Clark joined UnitedHealthcare in 2006 from InterActiveCorp, a consumer technology company comprised of leading digital brands, where he served as executive vice president, sales and marketing, for the Entertainment Publications division.
Follow Terry Clark:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Sanji Fernando
Vice President, OptumLabs Center for Applied Data Science of UnitedHealth Group
Sanji Fernando is the Vice President and Head of the OptumLabs Center for Applied Data Science. Sanji and his team are responsible for developing new software products implementing the latest innovations in big data technology and machine learning. Selected products are then developed and advanced for potential launch in the market. Before joining OptumLabs, Sanji was Head of Data Science at Nokia’s HERE’s Cloud Computing Group. The Data Science team was responsible for launching the first Big Data computing cluster at Nokia to analyze user activity and engagement. Previously, Sanji held positions in Nokia’s Advanced Business Development team and Nokia Research. Sanji started his career with Nokia as Portfolio Manager at Innovent, Nokia’s early stage venture fund. Before Nokia, Sanji was a co-founder of Vettro, an enterprise mobile application company, as well as consultant at Viant and Accenture.
Follow Sanji Fernando:
About Optum, Optum, Optum, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Rachel Gollub
Vice President of Benefitter Technology of UnitedHealth Group
Founder at Benefitter
Follow Rachel Gollub:
About Benefitter, HealthMarkets, UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Vinod Bidarkoppa
Senior Vice President and CIO of UnitedHealth Group
Vinod Bidarkoppa is the SVP and CIO at Optum Serve, a UnitedHealth Group Business.
Follow Vinod Bidarkoppa:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Vidya Raman-Tangella
Senior Vice President, and Head, UHC Innovation Center of Excellence of UnitedHealth Group
Vidya Raman-Tangella is leading innovation at the country’s largest health care company, helping people live healthier lives through an ongoing transformation of the health care system. Raman-Tangella heads UnitedHealthcare’s Innovation Center of Excellence, developing breakthroughs with practical solutions for improving health care quality, access and affordability. UnitedHealthcare is a subsidiary of UnitedHealth Group, which serves more than 132 million people worldwide. A physician-innovator with more than 20 years of experience in the health field, Raman-Tangella collaborates with diverse partners to develop simpler, more intelligent, and cost effective health care solutions. Her colleagues say she is exceptional with designing ecosystems that drive change in the health care market through the use of data and technology. Raman-Tangella and her team design, develop and scale breakthrough innovations that help address unmet health needs with holistic solutions. They use Human-Centered Design, outside-in thinking, and co-creation models to create meaningful solutions that deliver lasting value. Deep partnerships internally and strategic partnerships externally enable the team to create multi-faceted, holistic solutions. As a senior healthcare leader with a passion for personalized health journeys, she previously held an executive role at Johnson & Johnson, where she led the design of integrated and tailored health and wellness solutions for employers and health care plans. She was instrumental in the company’s start-up organization, providing expertise about strategic partnerships and enterprise integration. “My biggest career leap was entering the world of innovation from a world of clinical medicine,” Raman-Tangella said. “I have since learned that it is possible to have the best of both these worlds, and my daily quest is to find ways to pursue them both. This for me has resulted in a deep passion for the world of personalized health, medicine and health care.” She also says being a woman in her profession is fulfilling and fascinating. “I think women are inherently great at innovation, given their ability to think and apply multiple facets and look beyond the here and now,” she explained. Raman-Tangella’s desire to address unmet health care issues has led to the development and launch of several innovations, including the Baby Block program, a free online and mobile healthy-baby initiative. Another of her innovations is Solutions for Caregivers, a program for large employers featuring in-person, telephonic, and online resources designed to help caregivers save money and more effectively provide assistance to the people they support. Raman-Tangella holds a bachelor’s of medicine and a bachelor’s of surgery from Osmania University in India, and a master’s of health administration from Cornell University.
Follow Vidya Raman-Tangella:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Paul Lopez
Vice President Of Technology Development of UnitedHealth Group
Follow Paul Lopez:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Ben Wiegand
Senior Vice President, R&D of UnitedHealth Group
Follow Ben Wiegand:
About UnitedHealth Group: UnitedHealth Group is a healthcare company that offers insurance products and services for everyone.
Deepak Nath
President, Laboratory Diagnostics of Siemens Healthineers
Follow Deepak Nath:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Ron Pellegrini
Vice President & Head of Field Service LD/POC of Siemens Healthineers
Ron Pellegrini’s career with Siemens Healthcare spans over 20 years. It began as a licensed Medical Technologist specializing in Chemistry with the U.S. Air Force and at hospitals in Dallas / Fort Worth area. His experience led him to an engineering position with Ciba-Corning Diagnostics. He has held the position of Regional Service Manager and Technical Sales Manager for Chiron & Bayer Healthcare. He held the role of National Technical Sales Director at Siemens and was a Zone Vice President in the Midwest & Western Zones for both the In Vivo and In Vitro businesses prior to taking on his recent role as Vice President, Head of Field Service for LD/POC. Ron was awarded Rookie of the Year, Regional Manager & Director of the year, a three time President’s Club award winner and VP of the Year and a four time APEX winner while in his Service and Technical Sales Leadership positions. He is member of the American Medical Technologists (AMT), a mentor with the American Corporate Partners (ACP) for US Military Members, and is very active as a volunteer within his church community. Ron has been married for the past 29 years with four beautiful children. He enjoys traveling, golf and the watching the Dallas Cowboys. He holds Bachelors degree in Medical Technology from Midwestern State University in Wichita Falls, TX and has a Masters degree in Business.
Follow Ron Pellegrini:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Maynd Jolly
Vice President Strategic Corporate Accounts of Siemens Healthineers
Follow Maynd Jolly:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Sebastian Kronmueller
Vice President, Head of Strategy & Business Development – Laboratory Diagnostics of Siemens Healthineers
Sebastian Kronmueller incubates startup businesses within Healthineers with a focus on novel molecular applications. His current incubation businesses include the Siemens Healthcare Laboratory in Berkeley, California and NEO New Oncology in Cologne, Germany. Previously he led the execution of strategic initiatives as Head of Special Projects for Siemens Healthineers, playing an instrumental role in shaping the strategy of Siemens Healthineers in preparation for the IPO planned in 2018. Before this role he led a project management team for companion diagnostics and software development and was responsible for the carve-out and divestment of the Healthineers Microbiology business. He began his career as strategy consultant with Siemens Management Consulting. Sebastian holds a graduate degree in physics from Ludwig-Maximilians-University in Munich, Germany and a graduate certificate in Management Science and Engineering from Stanford University in Palo Alto, California.
Follow Sebastian Kronmueller:
About Siemens Healthineers: Siemens Healthineers is a healthcare technology company that provides diagnostic and therapeutic products and services.
Ros Deegan
President and Chief Business Officer of Bicycle Therapeutics
Ros Deegan, MBA, is president and chief business officer of Bicycle Therapeutics Inc., the U.S. subsidiary of Bicycle Therapeutics. Prior to joining Bicycle, Ros most recently served on the senior leadership team at Trevena, Inc. as senior vice president, business development and operations, and previously held the role of head of finance and operations. While at Trevena, she was responsible for start-up operations, negotiating a significant option and license agreement with Forest Laboratories, Inc., and leading finance and human resources through to the company’s first S-1 filing with the Securities and Exchange Commission. During her tenure, the company moved three programmes into the clinic, and raised over $200 million in private and public financings. Prior to joining Trevena, Ros served as director of business development at GSK in the U.S., leading transactions for the virtual immuno-inflammation group. Prior to that, she served as the director of operations for the Centre of Excellence for External Drug Discovery (CEEDD) and as marketing manager for GSK’s U.K. launch of Bonviva for post-menopausal osteoporosis and in business development. Ros holds a first-class degree from Cambridge University and received her MBA with distinction from INSEAD.
Follow Ros Deegan:
About Bicycle Therapeutics, Creative Destruction Lab (CDL), OMass Technologies: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Paul Chang
President, CEO/CSO and Lead Founder of ARase Therapeutics
Follow Paul Chang:
About ARase Therapeutics: Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Chad Clark
President of Precision for Medicine
Chad Clark is the President at Precision for Medicine.
Follow Chad Clark:
About Precision for Medicine, Precision Medicine Group: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Jared Kohler
Sr. Vice President, Project Management & Data Science Operations & Precision for Medicine of Precision for Medicine
Jared Kohler is the Sr. Vice President, Project Management & Data Science Operations, Precision for Medicine at Precision for Medicine.
Follow Jared Kohler:
About Precision for Medicine, Quartz Bio: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
Merry Lee
Vice President, Medical Device Regulatory Strategy of Precision for Medicine
Merry Lee Bain is the Vice President, Medical Device Regulatory Strategy at Precision for Medicine.
Follow Merry Lee:
About Precision for Medicine: Precision for Medicine is a specialized scientific services company helping life science innovators develop medical products.
David Cordani
President & CEO of Cigna
David Cordani is the President (since 2008) and Chief Executive Officer at Cigna since December 2009. David is also a Member of the Board of Directors at Cigna since 2013. David has led Cigna’s transformation from a traditional health insurer into a leading, global health service company, with a focus on helping people improve their health, well-being and sense of security. Since becoming President and Chief Executive Officer in 2009, Cordani has successfully galvanized Cigna’s more than 35,000 employees–in more than 30 countries–around a global product and service repositioning, guided by the company’s differentiating “Go Deep, Go Global, Go Individual” strategy. Previously, David was the Chief Operating Officer from June 2008 until December 2009, President of Cigna HealthCare from 2005 until 2008 and Senior Vice President of Customer Segments and Marketing for Cigna HealthCare from 2004 until 2005. David has been employed by Cigna since 1991. David is an accomplished triathlete, having competed in more than 125 triathlons. David earned a Bachelor’s degree from Texas A&M University and an MBA from the University of Hartford.
Follow David Cordani:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Eric Reed
Senior Vice President of Cigna
Follow Eric Reed:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Jackie Aube
Vice President of Personalization & Customer Strategy of Cigna
Follow Jackie Aube:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Christopher Moretti
Vice President of Cigna
Christopher Moretti has been an executive leader with Cigna since October, 2015 and is currently responsible for all infrastructure engineering Leading the Global Engineering & Infrastructure Services. In this role, Chris provides executive leadership over the teams that deliver Cigna’s voice & data networks, security engineering, contact center, database, compute, storage, information management, mainframe, cloud & devops. Previous to Cigna, Chris spent 14 years at General Electric and its subsidiaries in various executive leadership roles supporting its insurance, consumer and commercial banking businesses. While at GE, Chris attended and graduated many of their prestigious management training classes including AIMC and EIMP. Most recently, Christopher was Managing Director of Global Networks for J.P. Morgan Chase & Company based in midtown Manhattan. Chris started his career in IT performing many different hands on technical roles in client/server, network and security for various sized firms in the greater New York market including a period where he consulted for Greenwich Technology Partners. Chris earned a bachelor’s degree in economics from the University of Connecticut and currently resides in Shelton, CT with his wife and 3 sons.
Follow Christopher Moretti:
About Cigna: CIGNA Corporation operates as a health service company that helps people to improve the health, well-being, and peace of mind.
Alex Aravanis
Chief Technology Officer & Senior Vice President of Illumina
Follow Alex Aravanis:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Craig Ciesla
Vice President Advanced Engineering of Illumina
Follow Craig Ciesla:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Richard Klausner
Senior Vice President & Chief Medical Officer of Illumina
Richard Klausner joined Illumina in September 2013 as Senior Vice President and Chief Medical Officer. Richard is responsible for Illumina’s strategies for advancing genomics into clinical medicine and public health. He is also part of Illumina’s executive management team, which is responsible for directing all aspects of company strategy, planning and operations. Richard is a Scientific Advisor at Cyterix Pharmaceuticals Inc. He co-founded Pathwork Diagnostics, Inc. (Alternative name is Predicant Biosciences Inc.) in 2002. He serves as the Managing Partner at The Column Group LLC. He served as the Chairman of the Strategic Development and Scientific Advisory Council at Sanofi from March 1, 2011 to January 2013. Richard serves as the Chairman of the National Science Education Standards Projects of the National Academy of Science, overseeing the first comprehensive process to provide a vision of scientific literacy in the American educational system and the criteria required to achieve it. He served as Co-Chairman of the Scientific Advisory Board and Scientific Advisor at Aragon Pharmaceuticals, Inc. He served as an Executive Director for Global Health at the Bill & Melinda Gates Foundation. Richard served as the President at the American Society of Clinical Investigation. He served as an Advisor to the President of the Academies for counter-terrorism, and a Liaison to the White House Office of Science and Technology Policy. From 1979 to 1981, he worked at NIH in National Cancer Institute’s (NCI) Laboratory of Mathematical Biology. He served as a Director of Pathwork Diagnostics, Inc. and Immune Design Corp. He served as Director of 3-V Biosciences, Inc. He served as a Director of NCI from August 1, 1995 to 2001. He serves as a Member of Scientific Advisory Board at NGM Biopharmaceuticals, Inc., Immune Design Corp., Constellation Pharmaceuticals and Audax Health Solutions. Richard served as a Distinguished Scientific and Strategic Advisor of Aveo Pharmaceuticals, Inc. Richard currently sits on the board of Juno Therapeutics. He is also the Chief Strategy Advisor for USAID. He is a member of the National Academy of Sciences, the Institute of Medicine, and the American Academy of Arts and Sciences. He served as a Member of Scientific Advisory Board at Infinity Pharmaceuticals, Inc., Igenica, Inc. and T2 Biosystems, Inc. Rick holds an M.D. from Duke Medical School.
Follow Richard Klausner:
About Audax Health Solutions, Illumina, Pathwork Diagnostics: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Jay Flatley
President & CEO of Illumina
Jay was appointed President and CEO of Illumina in 1999 and oversaw the company’s expansion into the whole genome sequencing area with the acquisition of Solexa in 2006, and more recently into diagnostics and consumer sequencing. Under his leadership, Illumina has been named multiple times to the Deloitte & Touche Fast 50 and Fast 500 lists, as well as to the Forbes 25 Fastest-Growing Tech Companies (2007, 2009 and 2010), the Fortune 100 Fastest-Growing Companies (2010 and 2011) lists, and recognition by MIT Technology Review as the World’s Smartest Company in 2014. Previously, Jay served as President and Chief Executive Officer of Molecular Dynamics. As a co-founder and member of the board of directors for Molecular Dynamics he led the company to its initial public offering in 1993. He helped Molecular Dynamics develop and launch over 15 major instrumentation systems, including the first capillary-based DNA sequencer. Currently, he is an Advisory Board member for UC San Diego’s Moores Cancer Center, and a member of the Board of Directors at Coherent, Denali, and Illumina, Inc. Jay received a B.A. in economics from Claremont McKenna College and a B.S. and M.S. (summa cum laude) in industrial engineering from Stanford University.
Follow Jay Flatley:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
James Godsey
TitleVice President, Assay Development Dates Employed of Illumina
Follow James Godsey:
About Illumina: Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Erik Holmlin
President, CEO of Bionano Genomics
Erik Holmlin has two decades of experience in the life science and health care industries. His expertise spans technology development and commercialization, global marketing, commercial operations, venture financing, mergers & acquisitions and intellectual property. Recently, he served as president and CEO of GenVault Corporation, a life science company bring innovative solutions to biosample management. He merged GenVault with IntegenX, Inc. in January of 2011. He also served as an entrepreneur in residence (EIR) at Domain Associates, LLC, a leading dedicated life science venture-capital firm. Prior to these roles, Erik was chief commercial officer at Exiqon A/S, where he was responsible for global sales, marketing, and clinical affairs for two businesses: Oncology Services in a CLIA lab and Consumables Business in Life Sciences Research. In 2001 Mr. Holmlin led the formation of GeneOhm Sciences, Inc., for which, over a span of 5 years, he was director of chemistry, senior technology director, vice president of technology and business development, and vice president of marketing.
Follow Erik Holmlin:
About Bionano Genomics: BioNano Genomics develops nanoscale imaging and analytic platforms designed to analyze DNA and other genome-related peptides and proteins.
Simba Gill
President & CEO of Evelo Biosciences
Simba Gill, PhD is an entrepreneur, investor and CEO who believes passionately that science and globalization will dramatically improve life in the 21st century. Dr. Gill is currently the CEO of Evelo, Sr. Partner at Flagship Ventures, and Executive Chair of Blackfynn. Dr. Gill founded or had lead roles in moksha8, Epirus, Maxygen, Verdia, Avidia, Codexis, Systemix and Valentis, four of these companies have been taken public and three were acquired through strategic trade sales. Exit valuations were between $400M – $6B. Dr. Gill has also led, built and launched several commercial businesses/products generating annual revenues of between $150M-$2B. Dr. Gill has founded and/or had lead roles in pioneering companies in the fields of antibodies, stem cells, directed molecular evolution, immunodiagnostics and the cancer microbiome. He has also been an investor, advisor, founder and CEO of several emerging market life science companies. Dr. Gill was a Partner at TPG, focused on investments in Life Sciences and Emerging Markets. Early in his career, Dr. Gill was co-head of Worldwide Marketing for Recormon. He also led corporate and market development and strategy from inception to commercialization of the Elecsys system, which became one of the world’s most widely used immunodiagnostic platforms. Dr. Gill served on the Board of Directors of the Tuberculosis Alliance, The Djerassi Resident Artists Program and the International Advisory Board of INSEAD. Dr. Gill was also the founder of Dispatches, an in-depth written and photojournalism periodical focused on key global issues. Dr. Gill has an MBA from INSEAD and carried out his PhD with focus on developing humanized antibodies to treat cancer. This work was done at King’s College, London in collaboration with the LMB at Cambridge and Celltech.
Follow Simba Gill:
About Epiva, Evelo Biosciences, moksha8 Pharmaceuticals, TPG Growth: Evelo Biosciences is dedicated to improving the lives of patients globally through the development of monoclonal microbials.
Daniel Grau
President, Chief Executive Officer, and Director of Sojournix
Grau co-founded and has served as Chief Executive Officer and Director at Sojournix since 2016. An experienced biotech entrepreneur and operating executive, Mr. Grau led the deal to acquire SJX-653 and has driven the rapid growth and financing of the company from startup to clinical-stage pharmaceutical business. Prior to Sojournix, Mr. Grau served as President at Heptares Therapeutics (acquired 2015), Chief Executive Officer at Cortria (acquired 2010), and Chief Operating Officer at CombinatoRx (IPO 2005). Mr. Grau currently serves as an advisor to HotSpot Therapeutics and previously served as a member of the Product Advisory Board at Concert Pharmaceuticals and as an advisor to Nimbus Therapeutics. Earlier in his career, Mr. Grau worked with multi-national pharma companies as a management consultant focused on corporate and business franchise strategy, M&A, and new product launches. Mr. Grau earned his M.Phil., M.A., and M.A.R. degrees from Yale University, where he was awarded a Mellon Fellowship, the Day Graduate Prize, and a Bass Fellowship, and a B.A. with High Honors from Davidson College, where he held a Dana Honor Scholarship, a Montgomery Scholarship, and was elected to Phi Beta Kappa.
Follow Daniel Grau:
About Cortria Corporation, Heptares Therapeutics, Sojournix: Sojournix is a biotechnology company developing innovative medicines for women’s health and endocrine disorders.
Gary Loveman
Executive Vice President , Health Services Organization of Aetna
Gary Loveman joined Caesars Entertainment Corporation as Chief Operating Officer in 1998, after serving as an associate professor at the Harvard University Graduate School of Business Administration. He drew on his background in service-management to develop the gaming industry’s most successful loyalty and analytics program, Total Rewards, which boasts more than 40 million members. After being named CEO in January 2003, Loveman presided over a period of growth that included the 2004 purchase of Horseshoe Gaming and the World Series of Poker and the 2005 acquisition of Caesars Entertainment, Inc. In January 2008, Caesars went private in a $30.7 billion transaction led by private equity firms TPG Capital and Apollo. In the wake of the recent financial crisis, Loveman has led Caesars’ successful debt reduction and liquidity improvement strategies, while also adding Planet Hollywood and social games leader Playtika to the Company’s portfolio. Loveman was recognized as the gaming and lodging industry’s best CEO by Institutional Investor magazine for four consecutive years. After 12 years with the company, Loveman retired from his role as Chief Executive Officer and President in July 2015. Loveman is the past chairman of the American Gaming Association. He is a member of the President’s Export Council and serves as Chairman of the Business Roundtable’s Committee on Health and Retirement. He also serves as a director of Coach, Inc. and FedEx Corporation and sits on the Board of Trustees at Children’s Hospital Boston and the Visiting Committee of the Department of Economics at M.I.T. He holds a Ph.D. in economics from M.I.T., where he was an Alfred Sloan Doctoral Dissertation Fellow, and a B.A. in economics from Wesleyan University.
Follow Gary Loveman:
About Aetna, Well: Aetna a diversified health care benefits company, provides individuals and many others with innovative benefits, products, and services.
Austin Harkness
Executive Vice President, Operations of Honor
Follow Austin Harkness:
About Honor, Sunoco – Stores: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Maury Blackman
President & CEO of Premise Data
Maury Blackman is CEO of Premise Data. Blackman is a tech executive with more than 25 years of experience leading high growth enterprise software companies. His industry experiences include government, construction, public safety, geospatial information, GPO’s, sharing economy services, and drone software. Blackman joined Premise in 2017; under his leadership the company has seen 661% revenue growth. In November 2020, Premise was named to Deloitte’s Technology Fast 500, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America. Premise is the 35th fastest-growing company in the Silicon Valley region and is 182nd on the overall list. Before joining Premise, Blackman was CEO at Accela, a civic tech company aimed at moving citizen transactions from city hall to online and mobile services. He joined the company in 2000 as the VP of Sales and Marketing and then assumed the role of CEO in 2007. To support strategic initiatives and growth, he raised more than $300M in financing from family offices, private equity, and senior debt. The capital from these raises was deployed to build out an enterprise offering, expand internationally, and execute an M&A strategy that closed 10+ acquisitions in 24 months. Prior to joining Accela, Maury worked for Investools (NASDAQ:IEDU) where he served in several executive positions from 1993 to 2000. At Investools, he first joined as an Account Executive and was later appointed Vice President, Business Development charged with selling data and content to brokerage firms and internet service providers in the nascent dot-com era. In this capacity, he built a dynamic portfolio of accounts that included Charles Schwab, Fidelity, AOL, and Netcom Online Communications. For his accomplishments at Accela, Blackman was recognized by Government Technology as one of its Top 25 Doers, Dreamers, and Drivers in 2015. In 2016, Ernst and Young awarded him the prestigious Northern California’s Entrepreneur of the Year. Maury holds a B.A. in Political Science from the University of Houston and was a commissioned field artillery officer in the United States Army, serving on both active and reserve duty for 10 years. Maury maintains an active lifestyle and is an eleven-time Ironman finisher, including the 2008 and 2013 Ironman World Championship in Kailua-Kona.
Follow Maury Blackman:
About Premise Data: Premise is a data and analytics platform powered by a global network of on-the-ground contributors, data science, and machine learning.
Gioel Molinari
Executive Vice President & Chief Product Officer of Butterfly Network
Follow Gioel Molinari:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Zhen Li
Founder, President & CEO of ADARx Pharmaceuticals
Dr. Li is a co-founder of ADARx and a successful executive with more than two decades of diverse experience in research and development in the pharmaceutical and biotech industries. Prior to ADARx, Dr. Li served as Senior VP at Arrowhead Pharmaceuticals where she led the discovery and non-clinical development of Arrowhead’s delivery platform and multiple product candidates that are now in clinical studies. Previously, Dr. Li was a director at Merck, leading a team dedicated to siRNA development. Dr. Li received her Ph.D. in Chemistry and Chemical Biology from Harvard University, and her B.S. from Peking University.
Follow Zhen Li:
About ADARx Pharmaceuticals: ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Andrew Song
President and Co-Founder of Whisper
Andrew Song is the President and Co-Founder at Whisper.
Follow Andrew Song:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Alex Gourlay
Executive Vice President of Walgreens
Alex Gourlay joined Walgreens as Executive Vice President, President of Customer Experience and Daily Living in October 2013. In this new role, reporting to Walgreens President and Chief Executive Officer Greg Wasson, he leads an enhanced Walgreens daily living business operation overseeing customer experience, U.S. merchandising, marketing, customer insights, daily living products and promotions. Alex was previously Chief Executive, Health & Beauty Division, Alliance Boots, a role he undertook in January 2009, when he was also appointed to the Board of Alliance Boots. He had previously been Managing Director of Boots UK and a member of the Alliance Boots Group operating committee following the acquisition of Alliance Boots plc by AB Acquisitions Limited in 2007. Prior to this, he was Healthcare Director of Boots the Chemists, having held senior management positions in store operations and human resources.
Follow Alex Gourlay:
About Walgreens, Walgreens Boots Alliance: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kathleen Wilson-Thompson
Senior Vice President & Chief Human Resources Officer of Walgreens
Kathleen Wilson-Thompson is Senior Vice President & Chief Human Resources Officer at Walgreen Co.
Follow Kathleen Wilson-Thompson:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Rob Ewing
Regional Vice President of Walgreens
Rob Ewing is a Regional Vice President at Walgreens.
Follow Rob Ewing:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Abhi Dhar
Senior Vice President, Chief Information Officer of Walgreens
Abhi Dhar is senior vice president and chief information officer for Walgreen Co. based in Deerfield, Illinois. He is responsible for leading the information technology function and the company’s consumer-facing digital product and innovation efforts. He serves as a member of the Walgreens Enterprise Operating Committee with accountability for technology within the division. Prior to this role Dhar led the rapidly growing and award-winning mobile product/services business and simultaneously was responsible for end-to-end delivery, software development and technology innovation for the digital division within Walgreens. Dhar joined Walgreens in 2009 as group vice president and chief technology officer. Previously, he served as chief information officer (CIO) and senior vice president at TravelCLICK from 2006 to 2009, where he built a global IT and product delivery organization by restructuring the organization, recruiting top talent and optimizing vendor relationships. From 2001 to 2006, he held various top technology leadership roles with Cendant Corporation and its Travelport division. Dhar also worked in engineering and digital/online consulting capacities with PricewaterhouseCoopers and AT&T. Dhar earned an undergraduate degree in engineering from the National Institute of Engineering, Mysore University in India in 1993 and earned a master of science degree in engineering from the New Jersey Institute of Technology in 1995.
Follow Abhi Dhar:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Luke Rauch
Group Vice President, Customer Experience & General Manager, Owned Brands of Walgreens
Luke Rauch is the Group Vice President, Customer Experience & General Manager, Owned Brands at Walgreens.
Follow Luke Rauch:
About Walgreens: Walgreens provides multi-channel access to consumer goods and cost-effective pharmacy, health, and wellness services.
Kim D. Blickenstaff
President and Chief Executive Officer of Tandem Diabetes Care
Kim joined Tandem in August 2007, bringing more than 30 years of healthcare experience in finance, marketing management, sales and strategic planning. Prior to joining Tandem, he was Chairman, Chief Executive Officer and co-founder of Biosite Incorporated, a medical diagnostic company that was acquired by Inverness Medical Innovations for $1.8 billion in June 2007. Prior to founding Biosite, he held various finance, operations, research management, sales management, strategic planning and marketing positions with Hybritech Incorporated and Baxter Healthcare. Kim has been active in the medical device and diagnostics industry over the last 12 years, serving on the board of directors for innovative, young healthcare companies such as SenoRx and MediVation Incorporated. He holds a Masters of Business Administration from Loyola University Chicago’s Graduate School of Business.
Follow Kim D. Blickenstaff:
About Tandem Diabetes Care: Tandem Diabetes Care develops medical devices for the treatment of diabetes offering diabetic insulin pumps for adults and children.
Tricia Moriarty
Vice President of Finance and Administration of Excel Venture Management
Ms. Moriarty is the Vice President of Finance and Administration for Excel Venture Management bringing with her 10 years of private equity experience. In this capacity she oversees the operational, financial and administrative aspects of the firm including financial reporting, human resources, facilities and investor relations. Prior to Excel Venture, Tricia was Director of Finance and Administration for CB Health Ventures (CBHV) where she worked in a similar capacity managing venture funds with $150 million of capital under management. Prior to CBHV, she was a Manager in the Global Income Unit at State Street Corporation where she managed daily operations and client service for clients in the Asia Pacific region. Ms. Moriarty has a BS in Business Administration from Northeastern University where she graduated with honors.
Follow Tricia Moriarty:
About CB Health Ventures, Excel Venture Management: Excel Venture Management builds companies that apply transformative life science technologies to solve problems in healthcare and beyond.
Paul Molloy
President & CEO of ClearFlow
Paul has over twenty years experience of operations, executive management and Board work at public, private and VC funded medical device companies. Two IPO’s at previous companies, particularly as President & Managing Director orchestrating LMA’s successful 2005 SGX listing at a market capitalization of >$300m. LMA was recently acquired by Teleflex in a process that he brokered. Paul was a practicing CRNA until he joined Datascope Corp in NJ in 1989, obtaining his MBA from the University of Chicago’s Booth School of Business and rising through executive positions with leading medical device firms to CEO level in successive start ups, most recently completing the sale of VasoNova to Teleflex Inc. He has extensive global industry connections and has traveled, lived and worked in Asia, Europe and the USA, including substantial experience setting up and managing operations in Australia, Germany, Switzerland, Singapore, China, Japan, India and Latin America as well as serving on the Board of those local subsidiaries.
Follow Paul Molloy:
About ClearFlow: ClearFlow is a medical device company developing technologies to solve clinical problems associated with obstructed catheters.
William Cameron Powell
President, CMO and Co-Founder of Airstrip Technologies
An obstetrician by training, Dr. Cameron Powell stopped practicing in 2008 to focus full-time on the business of developing AirStrip, which he co-founded with Gene Powell and Trey Moore. It is that real-world medical experience that drives the continued development and expansion of the AirStrip healthcare solution suite.
Follow William Cameron Powell:
About Airstrip Technologies, San Antonio Academy, WellAware: AirStrip Technologies provides a platform that delivers critical patient information directly to a doctor’s smartphone, laptop or desktop.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Neeraj Sahni
Senior Vice President, Cyber Risk of Willis Towers Watson
Neeraj is a national cyber resource for Willis Tower Watson’s efforts on Network Security, Privacy and emerging Technology risks using Blockchain and Crypto assets. With broad understanding of enterprise security and knowledge of evolving regulatory laws pertaining to data privacy, he aligns very closely with the insurance markets who understand the complexities within Cyber and Tech E&O risk providing optimal risk transfer solutions for his clients. He was formally Director of Insurance at Kroll and Cyber Underwriter at AIG. Named a 2015 Power Broker by Risk and Insurance Magazine, Neeraj is a frequent speaker at cyber conferences and contributes on data security issues via social media and publications. He holds a Bachelor degree in Civil Engineering and received his Masters in Business Administration from Loyola University Chicago.
Follow Neeraj Sahni:
About Willis Towers Watson: Willis Towers Watson is a global advisory and solutions company that helps clients around the world turn risk into a path for growth.
Steve Miller
Vice President, Translational Medicine of Blueprint Medicines
Follow Steve Miller:
About Blueprint Medicines: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Ernie Sadau
President, CEO of CHRISTUS Health
Ernie Sadau is responsible for day-to-day operations of CHRISTUS Health and lends extensive expertise in developing programs to improve quality and clinical integration and preparing the organization to capitalize on the opportunities of the future. Ernie joined CHRISTUS as Senior Vice President of Patient and Resident Care Operations in 2006. His title was changed to Senior Vice President and Chief Operating Officer in 2008 as he expanded his role and oversight within the organization. Ernie also served as the Chief Diversity and Inclusion Officer for CHRISTUS Health, developing the strategic initiatives and processes to ensure that CHRISTUS is living out its commitment to valuing differences and strengthening the ministry’s culture of inclusion. Before joining CHRISTUS, Ernie served in many roles at Adventist Health System from 1983-2006, holding various executive positions in the organization’s many hospitals and systems, including Chief Financial Officer, Administrator, and President and CEO of Adventist Health System/Midwest in Hinsdale, Ill., which includes five hospitals, over 60 physician practices, surgery and imaging centers and several home care agencies. During his tenure with Adventist, Ernie led successful hospital acquisitions and joint ventures; implemented thriving physician recruiting, community relations and employee development programs and developed many necessary medical services in the communities he served, including opening the only freestanding Emergency Room in Illinois and a Level III Neonatal Intensive Care Unit. Ernie holds a master’s degree in Hospital Administration from Southwest Texas State University in San Marcos, Texas. He received his undergraduate degree in Business Administration from the University of North Texas. Ernie is a Fellow of the American College of Health Care Executives, and was named an Up & Comer by Modern Healthcare magazine in 2000, an award that honors rising young stars in the health care management field.
Follow Ernie Sadau:
About CHRISTUS Health: Christus Health is an international Catholic, faith-based, not-for-profit health system
Randy Osteen
ACIO, Vice President, Strategy and Applications of CHRISTUS Health
Follow Randy Osteen:
About CHRISTUS Health: Christus Health is an international Catholic, faith-based, not-for-profit health system
Florent Peyre
Co-Founder & President of Small Door
Follow Florent Peyre:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Amit Shah
Vice President Operations of Virta Health
Follow Amit Shah:
About Virta Health: Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Johannes Fruehauf
Founder, President & Executive Director of LabCentral
Johannes Fruehauf is the Founder & CEO LabCentral/Biolabs.He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).
Follow Johannes Fruehauf:
About Arkuda Therapeutics, BioLabs, Cequent Pharmaceuticals, Deltix, LabCentral, Mission BioCapital: LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at
Chris Robinson
Vice President Recruiting of Third Rock Ventures
Chris Robinson joined Third Rock Ventures in 2010. Chris has more than 15 years of research and development-focused recruiting experience in life sciences and high technology. During his executive search career, Chris has focused on senior level executive searches within R&D organizations of both public and private biopharmaceutical and medical device companies. Prior to joining Third Rock Ventures, Chris was the co-founder of Pivotal Search, a boutique life sciences executive search and recruiting consulting practice where he led business development and executed searches. Previous to founding Pivotal, Chris was also one of the founding members of a life sciences R&D practice at another national search firm. Before moving to the life sciences industry Chris was the recruiting manager for a venture-backed technology start-up, Taqua Systems, where he helped them grow from 20 people to 300 people in three locations. Chris holds a BS in Physiology from the University of Massachusetts, was honorably discharged from the United States Marine Corps and he is a Desert Storm veteran.
Follow Chris Robinson:
About Third Rock Ventures: Third Rock Ventures invests in transformational life science companies that show high growth potential
Jacqualyn Fouse
President and Chief Operating Officer of Celgene
Dr. Fouse serves as President and Chief Operating Officer. She assumed that role on March 1, 2016. In February 2016, Dr. Fouse was elected to the Board of Directors. Previously she was President, Global Hematology and Oncology since July 2014. Dr. Fouse joined the Company in September 2010 as Senior Vice President and Chief Financial Officer and became Executive Vice President and Chief Financial Officer in February 2012. Before Celgene, Dr. Fouse served as Chief Financial Officer of Bunge Limited, a leading global agribusiness and food company (Bunge), starting in July 2007. Before Bunge, Dr. Fouse was at Alcon Laboratories serving as Senior Vice President, Chief Financial Officer, and Head of Corporate Strategy at Alcon Laboratories between 2002 and 2007. Dr. Fouse was the Chief Financial Officer at Swissair Group from 2001 to 2002. Dr. Fouse held a variety of senior finance positions at Nestlé S.A. from 1993 to 2001, including serving as Group Treasurer of Nestlé from 1999 to 2001. Dr. Fouse also worked in finance at Alcon from 1986 to 1993 and held several positions, including Manager Corporate Investments and Domestic Finance. Earlier in her career, she worked at Celanese Chemical and LTV Aerospace and Defense. Dr. Fouse earned a B.A. and an M.A. in Economics and a Ph.D. in Finance from the University of Texas at Arlington. Dr. Fouse also serves as a member of the Board of Directors of Dick’s Sporting Goods (chairperson of the audit committee) and Perrigo Company (member of the audit committee), both NYSE-listed companies.
Follow Jacqualyn Fouse:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Robert M. Hershberg
Executive Vice President, Head of Business Development and Global Alliances of Celgene
Robert Hershberg (M.D., Ph.D.) Chief Executive Officer at VentiRX Pharmaceuticals.Dr. Robert Hershberg is a founder of VentiRx Pharmaceuticals and serves as Chief Executive Officer and member of the Board of Directors. VentiRx Pharmaceuticals is a clinical stage biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of cancer. The Company’s initial focus is developing novel small molecule product candidates targeting Toll-like receptor 8 (TLR8) for oncology and allergy. Prior to VentiRx, Dr. Hershberg served as Senior Vice President and Chief Medical Officer at Dendreon Corporation, developing immunotherapy approaches for cancer. In this capacity, Dr. Hershberg led the Clinical, Regulatory, and Biometrics groups, focusing on the development of Provenge™ in metastatic prostate cancer. Prior to joining Dendreon, Dr. Hershberg was the Vice President of Medical Genetics at Corixa Corporation (subsequently acquired by GSK). He led a research group focused on innate immunity and inflammatory disease, with a particular emphasis on Toll-like receptors (TLRs), and was an active member of the clinical development team for various products. Prior to joining Corixa, Dr. Hershberg was an Assistant Professor at Harvard Medical School and an Associate Physician at the Brigham and Women’s Hospital in Boston, Massachusetts.He completed his Undergraduate Degree in Molecular Biology and M.D. at UCLA, and his Ph.D. in Biology at the Salk Institute.Dr. Hershberg is clinically-boarded in Medical Genetics, and holds current clinical and research faculty positions at the University of Washington School of Medicine.
Follow Robert M. Hershberg:
About Celgene, VentiRx Pharmaceuticals: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Gerald Masoudi
Executive Vice President, General Counsel and Corporate Secretary of Celgene
Mr. Masoudi serves as Executive Vice President, General Counsel and Corporate Secretary. Mr. Masoudi joined Celgene in April 2015 from Covington & Burling LLP, a leading international law firm, where he was a partner and served as co-chair of the Food and Drug practice group. At Covington, he advised multinational companies and trade associations on significant litigation, enforcement, regulatory and public policy matters. Before joining Covington, Mr. Masoudi served as Chief Counsel of the U.S. Food and Drug Administration (FDA). Before joining the FDA as Chief Counsel, Mr. Masoudi served as Deputy Assistant Attorney General for international, policy and appellate matters in the Antitrust Division of the U.S. Department of Justice. Before his government service, Mr. Masoudi was a trial and litigation partner with the law firm Kirkland & Ellis. Immediately following his graduation from law school, he clerked for Judge Frank H. Easterbrook of the U.S. Court of Appeals for the Seventh Circuit. Mr. Masoudi received his J.D. from The University of Chicago Law School, graduating with high honors and serving on the editorial board of the Law Review. He received his B.A. in economics from Amherst College, Phi Beta Kappa.
Follow Gerald Masoudi:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Kristen Hege
Vice President, Translational Development, Hematology/Oncology of Celgene
Kristen Hege has served as a member of our board of directors since October 2018. Kristen Hege is currently a Clinical Professor of Medicine, Hematology and Oncology and an attending physician at the University of California, San Francisco (UCSF). She has held a clinical faculty appointment at UCSF since 1997 in the adult hematology and bone marrow transplant program. Kristen Hege has been board-certified in internal medicine, medical oncology and hematology. Kristen Hege received her B.A. summa cum laude from Dartmouth, M.D. from UCSF and completed a medical residency at Brigham & Women’s Hospital, Harvard Medical School and a fellowship in hematology and oncology at UCSF. She serves on the Board of Directors of the Society for Immunotherapy of Cancer, and Mersana Therapeutics and the Strategic Advisory Group for the Parker Institute for Cancer Immunotherapy. In 2015, FierceBiotech recognized her as one of the top 12 women in Biopharma. Kristen Hege currently serves as Corporate Vice President, Translational Development, Hematology and Oncology and San Francisco site head at Celgene where she is responsible for translational and early clinical development for all hematology and oncology products including small molecules, biologics and cell therapies. Prior to joining Celgene, she served as acting Chief Medical Officer at Aragon Pharmaceuticals, Theraclone Sciences and Cellerant Therapeutics. Kristen Hege began her career at Cell Genesys Inc. where she spent 14 years in various roles of increasing responsibility, ultimately leading the Clinical Research and Development organization.
Follow Kristen Hege:
About Celgene: Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Hal Pyke
Vice President of PetVet Care Centers
Follow Hal Pyke:
About PetVet Care Centers, United States Taekwondo Association: PetVet Care Centers is an operator of specialty and general practice animal hospitals in the United States.
Shannon Richey
Vice President & General Manager, Asterand Bioscience Detroit Operations of BioIVT
Follow Shannon Richey:
About Asterand, BioIVT: BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Amit Vohra
Co-Founder, President & CEO of Promaxo
Promaxo is led by Dr. Amit Vohra who is a serial entrepreneur, business strategist and advisor to several healthcare and technology startups. Amit is a Partner in Advanced Biopharma Consulting, a management consultancy offering strategic business development and commercialization services in the life sciences space. He also serves as an advisor to Cricking, MedDx and HealthyX and a strategy consultant to Precision Biopsy and Weinberg Medical Physics. Prior to Promaxo, Amit was the CEO/President of Convergent Life Sciences wherein he took a MRI-US fusion product, for targeted laser ablation of soft tissue cancer, through FDA clearance within 18 months of Company formation. Previously, as VP of Strategy and Operations at Eigen, he led the development and successful commercialization of two class II medical devices in the prostate biopsy space. In 2009, Amit co-founded Navya Biomedical Technologies, a biotechnology company using proprietary polyhydroxy fullerenes (PHF) for non-invasive imaging and destruction of solid tumors. Amit has a Doctorate in Mechanical Engineering from University of Florida, and an Executive MBA (Fuqua Scholar) from Duke University’s Fuqua School of Business.
Follow Amit Vohra:
About 8chili, Neuro42, Promaxo, TriOcula Technologies: Promaxo is commercializing customer-centric MRI systems and robotic guidance tools for live diagnosis and treatment in a physician’s office.
Kathryn Zavala
Vice President, Business Development & Operations of MedTech Innovator
Follow Kathryn Zavala:
About MedTech Innovator: MedTech Innovator is the largest lifescience accelerator in the world for medical device, digital health, and diagnostic companies
Irv Edwards
Founder & President of Emergent Medical Associates
Dr. Irv Edwards obtained his Bachelor’s Degree from McGill University and his Medical Degree from the University of Calgary in Alberta, Canada. He came to Los Angeles to pursue his interest in Emergency Medicine and interned at Los Angeles County Hospital. After his internship, Dr. Edwards completed his residency in Emergency Medicine at Harbor UCLA Medical Center. Following his residency, Dr. Edwards pursued private practice at a variety of hospital sites in Los Angeles and Orange Counties including Chino Valley Medical Center, Encino-Tarzana Regional Medical Center, La Palma Intercommunity Hospital, Mission Community Hospital, Montclair Hospital Medical Center, Olympia Medical Center, Sherman Oaks Hospital, and Valley Presbyterian Hospital. He was the Director of Performance Improvement at Mission Community Hospital from 1998 – 2003 and he currently serves as the Director of Case Management at Mission Community Hospital and as the Chief of Staff at Chino Valley Medical Center. He is the Director of Emergency Services at Chino Valley Medical Center, Encino-Tarzana Regional Medical Center, Mission Community Hospital, and Montclair Hospital Medical Center. In 1989, Dr. Edwards founded Emergent Medical Associates and has served as its President since inception. Since 2001, Dr. Edwards has been a dedicated member of CAL/ACEP and he currently sits on their Executive Board. He served as its President from 2005-2006.
Follow Irv Edwards:
About Emergent Medical Associates: Emergent Medical Associates is a provider of emergency care and episodic care management services to patients.
Andrew Jacobus
Vice President – Global Insights and Data Science Leader of Virgin Pulse
Follow Andrew Jacobus:
About Limeade, Virgin Pulse: Virgin Pulse, part of the famed Virgin Group, is passionate about inspiring and engaging employees to live better every day.
Agatha Martindale
Vice President and Global Finance of Rakuten Medical
Follow Agatha Martindale:
About BUILTBYGIRLS, Rakuten Medical, Rakuten Medical: Rakuten Medical is a biotechnology company that develops therapies to treat cancer.
Christine Lemke
Co-Founder & President of Evidation Health
As Chief Product Officer, Christine leads product management and development at Evidation Health. Previously, Christine co-founded and led The Activity Exchange, an insight and personalization platform that helps healthcare companies deliver the right digital interventions and incentives to consumers to help them achieve sustainable behavior change. Prior to her work in healthcare, Christine was the co-founder and Chief Operating Officer of Sense Networks, developers of the first machine learning platform for mobile phone activity data (exited to YP.com). She has also held roles at 3iGroup (Paris), Microsoft XBOX and co-founded Chicago-based Channel IQ, a product analytics platform. Christine has a BA from the University of Washington and an MBA from HEC Paris.
Follow Christine Lemke:
About Evidation Health, Evidation Health: We enable and empower everyone to participate in better health outcomes.
Tim Tompkins
Vice President & Deputy Chief Information Security Officer of CVSHealth
Vice President & Deputy Chief Information Security Officer at CVS Health.
Follow Tim Tompkins:
About CVSHealth: CVS Health provides an integrated healthcare services offering for its members.
